Direct-Acting Antivirals in Kidney Transplant Patients: Successful Hepatitis C Treatment and Short-Term Reduction in Urinary Protein/Creatinine Ratios

BACKGROUND: The role of Hepatitis C Virus (HCV) clearance in kidney graft survival is unknown. We examined short-term trends of protein/creatinine (P/C) ratios in HCV-infected kidney transplant recipients treated with direct-acting antivirals (DAAs). METHODS: This is a retrospective study of 19 kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetsch, Michael R., Tamhane, Ashutosh, Varshney, Mohit, Kapil, Anuj, Overton, Edgar T., Towns, Graham C., Franco, Ricardo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654569/
https://www.ncbi.nlm.nih.gov/pubmed/29075676
http://dx.doi.org/10.20411/pai.v2i3.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654569/
https://www.ncbi.nlm.nih.gov/pubmed/29075676
http://dx.doi.org/10.20411/pai.v2i3.211

Ejemplares similares